saypha® filler Lidocaine
Health Canada Approved (Licence #71479)
A cross-linked hyaluronic acid dermal filler designed to correct light to moderate nasolabial folds. Integrated 0.3% lidocaine ensures enhanced patient comfort during treatment.
Key Benefits
- Enhanced comfort with lidocaine
- High-quality HA concentration (23 mg/mL)
- Visible results for up to 6 months
- Smooth, transparent, and viscoelastic gel for uniform distribution
Indications (Canada)
saypha® filler Lidocaine is indicated for injection into the mid to deep dermis to correct light to moderate nasolabial folds.
Product Specifications
| HA Concentration |
23 mg/mL |
| Lidocaine |
0.3% |
| Crosslinking Agent |
BDDE (≤2 ppm) |
| Injection Depth |
Mid to Deep Dermis |
| Syringe Volume |
1.0 mL prefilled syringe |
| Needle |
2 x 27G ½” needles (included) |
| Sterilization |
Steam sterilized |
Exclusion Criteria
- Not for use in periorbital or glabellar regions
- Contraindicated in autoimmune diseases or hypersensitivity to HA or lidocaine
- Not for use in pregnancy, breastfeeding, or patients under 18
- Do not inject into inflamed, infected, or acneic skin
This medical device is intended for use by licensed healthcare professionals only. Always consult the Instructions for Use before administration.
